Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 33Pain, Postoperative 4Chronic Pain 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Breast Diseases 2Brain Neoplasms 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Skin Diseases 1Seroma 1Recurrence 1Radiation Injuries 1Postoperative Hemorrhage 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Site 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Hot Flashes 1Hodgkin Disease 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Gangliosidosis, GM1 1Gangliosidoses 1

Interventions

Testosterone 2Water 1Testosterone Propionate 1Sodium Chloride 1Laser Therapy 1Fish Oils 1Fatty Acids, Omega-3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyspareunia × Sodium Chloride × Breast × Clear all
NCT01539317 2017-04-14

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

OHSU Knight Cancer Institute

Phase 3 Completed
50 enrolled 9 charts
Breast

Breast Neoplasms, Dyspareunia, Vulvodynia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡